Table 3. Gene mutations observed in more than one sample and histological subtypes.
| Gene | Mutated samples n (%) | Histological Types (ULMS/ESS/UCS/ADS/ULM) |
|---|---|---|
| TP53 | 11 (48%) | 4 ULMS, 3 ESS, 4 UCS |
| ATM | 5 (22%) | 2 ULMS, 2 ESS, 1 UCS |
| PIK3CA | 4 (17%) | 1 ESS, 3 UCS |
| KMT2D | 3 (13%) | 1 ULMS, 1 ESS, 1 UCS |
| MTOR | 3 (13%) | 1 ESS, 1 UCS, 1 ULM |
| JAK3 | 3 (13%) | 1 ULMS, 1 ESS, 1 ULM |
| APC | 3 (13%) | 1 ULMS, 2 ESS |
| DICER1 | 3 (13%) | 1 ESS, 2 UCS |
| TRRAP | 3 (13%) | 2 UCS, 1 ADS |
| TSC2 | 3 (13%) | 2 ULMS, 1 ADS |
| PDE4DIP | 3 (13%) | 3 ESS |
| AR | 2 (9%) | 1 ESS, 1 UCS |
| ATRX | 2 (9%) | 1 ULMS, 1 ESS |
| CREBBP | 2 (9%) | 1 ULMS, 1 ESS |
| DNMT3A | 2 (9%) | 1 UCS, 1 ADS |
| EPHA7 | 2 (9%) | 1 UCS, 1 ADS |
| KAT6B | 2 (9%) | 1 UCS, 1 ADS |
| KMT2A | 2 (9%) | 1 ULMS, 1 ULM |
| MET | 2 (9%) | 1 UCS, 1 ULM |
| MYB | 2 (9%) | 1 ULMS, 1 ESS |
| NOTCH1 | 2 (9%) | 1 ULMS, 1 UCS |
| PRKDC | 2 (9%) | 1 UCS, 1 ADS |
| SYNE1 | 2 (9%) | 1 ULMS, 1 ESS |
| NF1 | 2 (9%) | 1 ESS, 1 UCS |
| NOTCH2 | 2 (9%) | 2 ULMS |
| HER2 | 2 (9%) | 2 ULMS |
| ERBB4 | 2 (9%) | 2 UCS |
| DAXX | 2 (9%) | 1 ESS, 1 ADS |
| ITGA10 | 2 (9%) | 2 ESS |
| DST | 2 (9%) | 2 ESS |